A popular dual agonist, tirzepatide (Mounjaro), activates both GLP-1R and GIPR, producing synergistic effects on insulin secretion, appetite suppression, and weight reduction (Table 1)
However, we were unable to account for the severity of psychiatric illness or healthcare access, which may influence both treatment allocation and suicidality risk
The Two Micron All Sky Survey (2MASS)
Humatrope pens, Genotropin GoQuick, and Saizen click.easy all publish 28-day in-use stability
Severe or persistent symptoms including severe abdominal pain, persistent vomiting, right upper quadrant pain, or signs of pancreatitis require urgent medical assessment
Percentages were calculated using year-end reported financial results from Merck for 2021 and AbbVie for 2022